Petition to Ban Diabetes Drug Liraglutide (Victoza)
April 19, 2012
View as PDF
View press release
Public Citizen petitions the Food and Drug Administration (FDA) to immediately remove from the market the diabetes drug liraglutide (Victoza; Novo Nordisk) because the known increased risks of thyroid cancer and pancreatitis outweigh any documented clinical benefits.
October 15, 2012, Interim response from FDA.
March 25, 2014, Final response from FDA.